Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of NMRA-898, a M4 Positive Allosteric Modulator.
Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc. announced the presentation of new preclinical data …
Vesper Solar 600 MW Texas Project The Vesper Solar 600 MW Texas project demonstrates how an agrivoltaics mindset can unlock prime sites fo…
Scientists Say This 5-Minute Trick Could Help You Live Longer New research suggests it could be the key to boosting heart and lung health.…
ASX Market Update The Australian stock market is experiencing a decline, led by significant losses in the healthcare and tech sectors, des…
Leatt Releases New Outerwear and Glasses for 2026 Leatt has introduced its new 2026 range of outerwear and sunglasses in its 2026 mountain…
Pole-mount Agrivoltaics Project at Puerto Rico Coffee Farm A new agrivoltaics system has been installed at a coffee farm in Adjuntas, Puer…
Potential Human Pandemic from Bird Flu Strain A bird flu virus, H9N2, has the potential to spark a human pandemic, according to a team of …
Abbott Directed to Provide Prescribing Details for Triamcinolone Hexacetonide Pre-Filled Syringe The Subject Expert Committee (SEC) under …
Lululemon to Sell NFL Apparel in Fanatics Deal Lululemon has entered an arrangement with the NFL and Fanatics to develop a line of fan app…
Councils' Role in New Towns Success Peers have emphasized the importance of councils in making the New Towns programme a success. A…